# Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

Study · id `cardio:ct-nct04718025` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04718025](<https://clinicaltrials.gov/study/NCT04718025>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04718025

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 4500 participants.

## Technical summary

Registry record NCT04718025. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-07 (actual); primary completion 2024-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 4500 participants (planned count; ClinicalTrials.gov record NCT04718025, source copy `cardio:ctgov-nct04718025-2023-04-21`, retrieved 2026-10-26)
- Started: 2022-02-07 (actual) (ClinicalTrials.gov record NCT04718025, source copy `cardio:ctgov-nct04718025-2023-04-21`, retrieved 2026-10-26)
- Primary completion: 2024-06-30 (anticipated) (ClinicalTrials.gov record NCT04718025, source copy `cardio:ctgov-nct04718025-2023-04-21`, retrieved 2026-10-26)
- Completion: 2024-06-30 (anticipated) (ClinicalTrials.gov record NCT04718025, source copy `cardio:ctgov-nct04718025-2023-04-21`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT04718025, source copy `cardio:ctgov-nct04718025-2023-04-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04718025-2023-04-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
- Acronym: ELECTRA-SIRIO
- Condition: STEMI
- Condition: NSTEMI
- Condition: Unstable Angina
- Intervention (Drug): Ticagrelor 90mg
- Intervention (Drug): Ticagrelor 60mg
- Intervention (Drug): Aspirin
- Lead sponsor: Collegium Medicum w Bydgoszczy
- Lead sponsor class: OTHER
- Collaborator: Medical Research Agency, Poland
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Collegium Medicum w Bydgoszczy (`cardio:org-collegium-medicum-w-bydgoszczy`)
- Registry lists this organization as a collaborator: Medical Research Agency, Poland (`cardio:org-medical-research-agency-poland`)

## Provenance

Content hash: 15a9c395ae6d9ae11517b0c0d316fa5628ec11412c23d39cb853525232fbfefb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
